Lipidor AB Logo

Lipidor AB

Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.

LIPI | ST

Overview

Corporate Details

ISIN(s):
SE0012558617 (+1 more)
LEI:
549300OC9DDXCE1GMX60
Country:
Sweden
Address:
C/O Ekonomistubben AB, 102 16 Stockholm
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Lipidor AB is a pharmaceutical research and development company specializing in topical treatments for skin diseases. The company's core asset is its proprietary lipid-based drug delivery platform, AKVANO®. Lipidor's business model focuses on reformulating existing active pharmaceutical ingredients into new, innovative, and patient-friendly treatments. This approach offers an accelerated path to regulatory approval and commercialization for its global pharmaceutical partners. The AKVANO® platform is designed to enhance patient compliance by creating formulations that are easy to apply, quick-drying, and less likely to cause skin irritation. The company maintains a pipeline of development projects in various pre-clinical and clinical phases for a wide range of dermatological conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Lipidor AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Lipidor AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Lipidor AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.